Cargando…
DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis
BACKGROUND & AIMS: Gastrointestinal cancer stem cell marker doublecortin-like kinase (DCLK1) is strongly associated with poor outcomes in colorectal cancer (CRC). Although DCLK1’s regulatory effect on the tumor immune microenvironment has been hypothesized, its mode of action has not been shown...
Autores principales: | Yan, Rui, Li, Jianjian, Xiao, Zeru, Fan, Xiaona, Liu, Heshu, Xu, Ying, Sun, Ruya, Liu, Jian, Yao, Jiannan, An, Guangyu, Shi, Yan, Ge, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791173/ https://www.ncbi.nlm.nih.gov/pubmed/36309200 http://dx.doi.org/10.1016/j.jcmgh.2022.10.013 |
Ejemplares similares
-
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022) -
Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling
por: Liu, Heshu, et al.
Publicado: (2023) -
DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
por: Yan, Rui, et al.
Publicado: (2023) -
DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells
por: Liu, Heshu, et al.
Publicado: (2019) -
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)